Results showed 25.9% of patients in the resmetirom 80 mg group and 29.9% of patients in the 100 mg group achieved MASH resolution with no worsening of fibrosis compared with 9.7% of those in the placebo group
As employers test out various strategies, one thing is certain: the ideal UM strategy integrates with broader workplace health initiatives
Similarly, adult obesity rates in England have put us in another shock
Use it as a weekly treatment to help restore tired-looking skin, improve the appearance of visible aging, and support a healthier-looking glow
GHK-Cu's dermal-matrix work (PMID 26236730, PMID 29986520), BPC-157's wound-healing literature (PMID 34267654), and TB-500's parent dermal-healing review (PMID 27450738) collectively provide three complementary foundations
Do I need to qualify before receiving semaglutide